Junshi Biosciences Revenue and Competitors
Estimated Revenue & Valuation
- Junshi Biosciences's estimated annual revenue is currently $13.8M per year.
- Junshi Biosciences's estimated revenue per employee is $155,000
Employee Data
- Junshi Biosciences has 89 Employees.
- Junshi Biosciences grew their employee count by -13% last year.
Junshi Biosciences's People
| Name | Title | Email/Phone |
|---|
Junshi Biosciences Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $99.4M | 458 | 40% | N/A | N/A |
#2 | $20.6M | 133 | 22% | N/A | N/A |
#3 | $156.1M | 146 | -70% | $145M | N/A |
#4 | $3.5M | 45 | -25% | $150M | N/A |
#5 | $1.6M | 21 | 0% | $459.5M | N/A |
#6 | $67.3M | 310 | 16% | $180.7M | N/A |
#7 | $8.5M | 55 | -2% | N/A | N/A |
#8 | $256.3M | 1025 | 9% | $168.5M | N/A |
#9 | $2.8M | 18 | -33% | N/A | N/A |
#10 | $9.1M | 59 | -9% | N/A | N/A |
What Is Junshi Biosciences?
Junshi Biosciences is an innovation-driven biopharmaceutical company which is dedicated to the discovery and development of innovative drugs and their clinical research and commercialization on a global scale. Our mission is to provide patients with treatment options that work better and cost less.
keywords:N/A
N/A
Total Funding
89
Number of Employees
$13.8M
Revenue (est)
-13%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Junshi Biosciences News
Coherus and Junshi Biosciences Announce PD-1 Inhibitor Toripalimab Granted Orphan Drug Designation for Small Cell Lung Cancer in the United...
Junshi Biosciences Announces FDA Approval of Investigational New Drug Application for Anti-CD112R Monoclonal Antibody for Treatment of...
Founded in December 2012, Junshi Biosciences (HKEX: 1877; SSE: 688180) is an innovation-driven biopharmaceutical company dedicated to the...
Other Companies in Shanghai
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $18.9M | 90 | 34% | N/A |
#2 | $13.3M | 92 | -2% | N/A |
#3 | $28.4M | 93 | 3% | N/A |
#4 | $19.5M | 95 | 2% | N/A |
#5 | $15.5M | 100 | -2% | N/A |